Genetics-diet crossroads: Unveiling new insights into hypertrophic cardiomyopathy.
作者信息
Häseli Steffen P, Schiattarella Gabriele G
机构信息
Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité-Universitätsmedizin Berlin, Berlin, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
出版信息
J Mol Cell Cardiol Plus. 2023 Sep 19;6:100051. doi: 10.1016/j.jmccpl.2023.100051. eCollection 2023 Dec.
Abstract
摘要
相似文献
1
Genetics-diet crossroads: Unveiling new insights into hypertrophic cardiomyopathy.遗传学与饮食的交叉点：揭示肥厚型心肌病的新见解
J Mol Cell Cardiol Plus. 2023 Sep 19;6:100051. doi: 10.1016/j.jmccpl.2023.100051. eCollection 2023 Dec.
2
Unveiling Clinical and Genetic Distinctions in Pure-Apical Versus Distal-Dominant Apical Hypertrophic Cardiomyopathy.揭示单纯心尖部肥厚型心肌病与远端优势型心尖部肥厚型心肌病的临床及遗传差异
J Am Heart Assoc. 2025 Mar 18;14(6):e038208. doi: 10.1161/JAHA.124.038208. Epub 2025 Mar 7.
3
Genetics and cardiomyopathy: where are we now?遗传学与心肌病：我们目前的进展如何？
Cleve Clin J Med. 2005 Jun;72(6):465-6, 469-70, 472-3 passim. doi: 10.3949/ccjm.72.6.465.
4
Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy (HOCM): Is HOCM Passing Another Crossroads?用于肥厚性梗阻性心肌病（HOCM）的肌球蛋白抑制剂：HOCM是否正处于另一个十字路口？
Can J Cardiol. 2024 May;40(5):820-823. doi: 10.1016/j.cjca.2024.01.034. Epub 2024 Feb 3.
5
The Role of Multiple Mutations in Hypertrophic Cardiomyopathy - A New Universe to Discover: Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History.多重突变在肥厚型心肌病中的作用——一个有待探索的全新领域：基因负荷在肥厚型心肌病自然病史恶化中“有罪”的证据
Cardiology. 2024;149(5):451-454. doi: 10.1159/000539360. Epub 2024 Jun 14.
6
Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.肥厚型心肌病：遗传学与管理概述。
Biomolecules. 2019 Dec 16;9(12):878. doi: 10.3390/biom9120878.
7
[Crossroads between ischemic heart disease, hypertrophic cardiomyopathy and athlete's heart].[缺血性心脏病、肥厚型心肌病与运动员心脏之间的交叉点]
Semergen. 2015 Apr;41(3):e9-11. doi: 10.1016/j.semerg.2014.05.014. Epub 2014 Aug 3.
8
[Clinical and molecular genetics of hypertrophic cardiomyopathy].肥厚型心肌病的临床与分子遗传学
Orv Hetil. 1998 Aug 16;139(33):1965-71.
9
Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.家族性肥厚型心肌病：临床特征、分子遗传学及分子遗传学检测
Expert Rev Mol Diagn. 2004 Jan;4(1):99-113. doi: 10.1586/14737159.4.1.99.
10
Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?肥厚型心肌病的遗传学：一种、两种还是更多种疾病？
Curr Opin Cardiol. 2007 May;22(3):193-9. doi: 10.1097/HCO.0b013e3280e1cc7f.
本文引用的文献
1
Western Diet Causes Heart Failure With Reduced Ejection Fraction and Metabolic Shifts After Diastolic Dysfunction and Novel Cardiac Lipid Derangements.西方饮食导致射血分数降低的心力衰竭，并在舒张功能障碍和新型心脏脂质紊乱后引起代谢变化。
JACC Basic Transl Sci. 2023 Jan 25;8(4):422-435. doi: 10.1016/j.jacbts.2022.10.009. eCollection 2023 Apr.
2
Prevalence, incidence and mortality of hypertrophic cardiomyopathy based on a population cohort of 21.9 million in China.基于中国 2190 万人群的队列研究，肥厚型心肌病的患病率、发病率和死亡率。
Sci Rep. 2022 Nov 5;12(1):18799. doi: 10.1038/s41598-022-20042-9.
3
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry.欧洲心脏病学会（ESC）欧洲观察性研究计划（EORP）心肌病/心肌炎登记处中肥厚型心肌病患者常见心血管危险因素与临床表型的关系。
Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):42-53. doi: 10.1093/ehjqcco/qcac006.
4
Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging.肥厚型心肌病的表型：遗传学、临床及模块化成像
Heart Fail Rev. 2021 Sep;26(5):1023-1036. doi: 10.1007/s10741-020-09931-1.
5
Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy.肥胖和代谢健康状况是肥厚型心肌病临床表型的决定因素。
Eur J Prev Cardiol. 2020 Nov;27(17):1849-1857. doi: 10.1177/2047487319889714. Epub 2019 Dec 1.
6
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).肥厚型心肌病的基因型与疾病终生负担：来自肌节性人类心肌病注册研究（SHaRe）的见解。
Circulation. 2018 Oct 2;138(14):1387-1398. doi: 10.1161/CIRCULATIONAHA.117.033200. Epub 2018 Aug 23.
7
Loss of Metabolic Flexibility in the Failing Heart.衰竭心脏中代谢灵活性的丧失。
Front Cardiovasc Med. 2018 Jun 6;5:68. doi: 10.3389/fcvm.2018.00068. eCollection 2018.
8
Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients.德国临床明显肥厚型心肌病的患病率：一项超过 500 万患者的分析。
PLoS One. 2018 May 3;13(5):e0196612. doi: 10.1371/journal.pone.0196612. eCollection 2018.
9
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.肥厚型心肌病：遗传学、发病机制、临床表现、诊断与治疗
Circ Res. 2017 Sep 15;121(7):749-770. doi: 10.1161/CIRCRESAHA.117.311059.
10
Genetics of hypertrophic cardiomyopathy: A review of current state.肥厚型心肌病的遗传学：现状综述。
Clin Genet. 2018 Jan;93(1):3-14. doi: 10.1111/cge.13027. Epub 2017 Aug 17.
Zotero 插件